Insiders · Profile

Yeleswaram Krishnaswamy

Chief Development Officer at Rapport Therapeutics. Filing since 31 Dec 2025. CIK 0002022156

Company

Date

Role

Action

Shares

Amount

Of holding

RAPP Rapport Therapeutics, Inc.

25 Aug 2026

Chief Development Officer

Sold on a plan

37,000

$1.87M

15.9%

RAPP Rapport Therapeutics, Inc.

24 Aug 2026

Chief Development Officer

Sold on a plan

13,160

$657.98K

5.3%

RAPP Rapport Therapeutics, Inc.

19 Aug 2026

Chief Development Officer

Sold on a plan

404

$20.16K

0.2%

RAPP Rapport Therapeutics, Inc.

17 Apr 2026

Chief Development Officer

Sold on a plan

20,225

$808.84K

7.6%

RAPP Rapport Therapeutics, Inc.

14 Apr 2026

Chief Development Officer

Sold on a plan

10,200

$357.80K

3.7%

RAPP Rapport Therapeutics, Inc.

13 Apr 2026

Chief Development Officer

Sold on a plan

9,165

$320.54K

3.2%

RAPP Rapport Therapeutics, Inc.

10 Apr 2026

Chief Development Officer

Sold on a plan

500

$17.49K

0.2%

RAPP Rapport Therapeutics, Inc.

8 Apr 2026

Chief Development Officer

Sold on a plan

360

$12.56K

0.1%

RAPP Rapport Therapeutics, Inc.

25 Mar 2026

Chief Development Officer

Sold on a plan

10,115

$303.35K

3.4%

RAPP Rapport Therapeutics, Inc.

31 Dec 2025

Chief Development Officer

Sold at will

2,840

$85.34K

0.9%

10 decisions on file.